作者的详细信息
Dashinimaev, Eh B, Department of Regenerative Medicine; Institute of Developmental Biology, Russian Academy of Sciences, Laboratory of Cell Proliferation, Pirogov Russian National Research Medical University
| 期 | 栏目 | 标题 | 文件 |
| 卷 91, 编号 5 (2019) | Editorial | The role of laboratory biomarkers in monitoring of rituximab biosimilar therapy (Acellbia, “BIOCAD”) in patients with rheumatoid arthritis |
 (Rus) |